ABBOTT LABORATORIES — Director's Dealing 2008

May 17, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-05-14

Reporting Person: Szela Mary T (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2008-05-14	Common shares without par value	M	2676	$42.4978	Acquired	98284	Direct
2008-05-14	Common shares without par value	M	1158	$43.00	Acquired	99442	Direct
2008-05-14	Common shares without par value	F	3101	$54.40	Disposed	96341	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-05-14	Option (right to buy)	$42.4978	M	2676	Disposed	2009-02-11	Common Shares (2676)	Direct
2008-05-14	Option (right to buy)	$43.00	M	1158	Disposed	2013-02-13	Common Shares (1158)	Direct
2008-05-14	Option (right to buy)	$54.40	A	2090	Acquired	2009-02-11	Common Shares (2090)	Direct
2008-05-14	Option (right to buy)	$54.40	A	1011	Acquired	2013-02-13	Common Shares (1011)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	7916	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of May 14, 2008.

F2: Employee stock option, including replacement option feature, granted pursuant to Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.